COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT05212831


Column Value
Trial registration number NCT05212831
Full text link
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

First author
Last imported at : July 16, 2023, midnight
Source : ClinicalTrials.gov

Not reported

Contact
Last imported at : July 16, 2023, midnight
Source : ClinicalTrials.gov

Not reported

Registration date
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

2022-01-28

Recruitment status
Last imported at : July 16, 2023, midnight
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

Crossover

Masking
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

Long covid

Inclusion criteria
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

inclusion criteria: ability and willingness to give written informed consent prior to any study-specific screening procedures and to comply with the requirements of the study male or female, aged ≥ 18 years of age diagnosed with long-covid patient self-reported concerns regarding cognitive functioning or recent diagnosis of covid-19 related cognitive impairment moca test scores ranging from 13 to 25/30 at screening oxygen saturation spo2 ≤ 93 % on fingertip pulse oximetry and/or < 60% on brain nirs, at rest or during effort and/ or 10% relative decrease in brain saturation during exercise as compared to baseline value at screening ability to perform exercise treadmill test at screening tolerability of pulsed oxygen (o2) therapy delivered by poc at screening willingness and ability to wear poc.

Exclusion criteria
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

contraindication to the use of poc including allergy to cannula material pregnancy or planning to become pregnant during the study non-covid-related cause for cognitive impairment (such as parkinson's disease, multiple sclerosis, alzheimer's disease, stroke, brain tumor, or dementia) subjects with respiratory infection at screening or randomization and/or acute bronchitis requiring antibiotics at the time of randomization or expected during the treatment participation in other interventional clinical trial within 30 days of randomization or expect to participate in any other investigational clinical trial during the conduct of this trial subjects who should be excluded in the opinion of the investigator

Number of arms
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

Inogen Inc.

Inclusion age min
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : Aug. 6, 2022, 5 p.m.
Source : ClinicalTrials.gov

Canada

Type of patients
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

Patients recovered from covid

Severity scale
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : July 16, 2023, midnight
Source : ClinicalTrials.gov

21

primary outcome
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

COVID-19 related brain hypoxia and peripheral oxygen saturation;MoCA test;Other neuropsychological tests;VO2max during cardiopulmonary exercise test

Notes
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 2135, "treatment_name": "Portable oxygen concentrator", "treatment_type": "Gas inhalation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]